High income

Income level is one of the strongest predictors of a country's disease burden and mortality profile. High income countries share common patterns in healthcare spending, infrastructure capacity, and population demographics that shape their leading causes of death. The World Bank classifies countries into four income groups based on gross national income per capita.

Use this page to compare mortality across high income nations and explore how economic development relates to health outcomes. Data is sourced from the IHME Global Burden of Disease Study 2023.

High-income countries — those with GNI per capita above approximately $13,845 (2023 World Bank threshold) — have largely completed the epidemiological transition, with non-communicable diseases accounting for approximately 88% of all deaths. Cardiovascular disease, cancer, dementia, and chronic respiratory disease dominate the mortality profile. Life expectancy typically exceeds 78 years, and in leading nations such as Japan, Switzerland, and Australia, it surpasses 83 years. Under-five mortality rates average below 6 per 1,000 live births — a stark contrast to low-income settings. However, high income does not guarantee health equity: the United States, despite the highest per-capita health spending globally, has lower life expectancy than many peer nations due to disparities in healthcare access, the opioid epidemic, gun violence, and obesity. Within high-income countries, socioeconomic gradients in mortality are substantial: in England, the gap in life expectancy between the most and least deprived areas exceeds 9 years for men. Ageing populations present the defining health challenge: rising dementia prevalence, multimorbidity, and healthcare workforce shortages strain systems designed for acute care rather than chronic disease management. Mental health disorders, substance use, and deaths of despair (drug overdose, alcohol, suicide) have emerged as significant and growing mortality concerns, particularly in North America.

High-income health systems are characterised by universal or near-universal coverage (with the notable exception of the United States), high health worker density (typically >30 physicians per 10,000 population), advanced diagnostic and therapeutic infrastructure, and substantial investment in biomedical research. Health spending averages 8-12% of GDP. Most operate through either single-payer (Canada, UK, Nordic countries), social insurance (Germany, France, Japan), or mixed models. Challenges include controlling pharmaceutical and technology-driven cost escalation, integrating care for complex multimorbidity, reducing wait times, addressing rural healthcare access gaps, and managing the fiscal implications of population ageing. Primary care gatekeeping, digital health adoption, and value-based payment models are common reform directions.

The high income category encompasses 86 countries and territories in this dataset, including United States, Russian Federation, Japan, Germany, United Kingdom, France, Italy, and Korea, Rep.. Explore individual country pages to see how mortality profiles vary within this income classification and how national policies and health investments shape outcomes across different causes of death.